PW Medtech Group's ROE % for the quarter that ended in Dec. 2025 was 1.43%. PW Medtech Group's PB Ratio for the quarter that ended in Dec. 2025 was 0.41.
PW Medtech Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 3.49%.
PW Medtech Group ROE % Adjusted to Book Value Related Terms
PW Medtech Group ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for PW Medtech Group's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PW Medtech Group ROE % Adjusted to Book Value Chart
FRA:PWE vs ISRG, BDX, MDLN: ROE % Adjusted to Book Value Comparison
For the Medical Instruments & Supplies subindustry, PW Medtech Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PW Medtech Group ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where PW Medtech Group's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 3.49% mean?
PW Medtech Group (FRA:PWE) has a ROE % Adjusted to Book Value of 3.49% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on PW Medtech Group and its competitors.
Is PW Medtech Group's ROE % Adjusted to Book Value too high?
PW Medtech Group's current ROE % Adjusted to Book Value is 3.49%. Overall, PW Medtech Group has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does PW Medtech Group's ROE % Adjusted to Book Value compare to ISRG and BDX?
PW Medtech Group's ROE % Adjusted to Book Value of 3.49% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on PW Medtech Group and its competitors. PW Medtech Group's current ROE % Adjusted to Book Value is 3.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PW Medtech Group stock overvalued right now?
PW Medtech Group (FRA:PWE) has a current ROE % Adjusted to Book Value of 3.49%. The stock's GF Value™ is €0.13, compared to a current price of €0.11 — trading 18.5% below its estimated fair value. The current ROE % Adjusted to Book Value is 3.49%. PW Medtech Group's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For PW Medtech Group (FRA:PWE), the current ROE % Adjusted to Book Value is 3.49% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PW Medtech Group (FRA:PWE) Overvalued in 2026?
Based on GuruFocus' analysis, PW Medtech Group stock appears to be undervalued.
The current stock price of €0.11 is trading 18.5% below its estimated GF Value™ of €0.13.
Key valuation signals for FRA:PWE:
ROE % Adjusted to Book Value: 3.49%
GF Value™: €0.13 vs. price of €0.11 (18.5% below fair value)
No single metric tells the full story. See the FRA:PWE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PW Medtech Group Ltd is a medical device company focused on China's medical device industry. The Group operates in infusion sets, blood purification products, and regenerative medical biomaterials. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, insulin needles and pens, high flux and low flux hemodialyzers, hemodiafilters, hemoperfutors, and dialysis machines. Its segments are Infusion Set Business, Blood Purification Business, which represents the R&D, manufacturing, and sales of hemodialysis and blood purification medical devices, and Regenerative Medical Biomaterials Business, which generates maximum revenue. Geographically, it operates in China, North America, India and Others.
84GF Score
Get the complete analysis for FRA:PWE
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PWE has been successfully added to your 
